CALIXA THERAPEUTICS INC has a total of 14 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are TENNOR THERAPEUTICS LTD, HUANG YONGHUA and Shenzhen zhijun pharmaceutical co ltd.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Damour Nicole Miller | 9 |
#2 | Terracciano Joseph | 9 |
#3 | Jurkauskas Valdas | 5 |
#4 | Jiang Chun | 3 |
#5 | Mudur Sanjay | 3 |
#6 | Fogliato Giovanni | 3 |
#7 | Duong Lisa | 3 |
#8 | Woertink Jason | 3 |
#9 | Moshos Kristos Adrian | 3 |
#10 | Resemini Dario | 3 |
Publication | Filing date | Title |
---|---|---|
US2015094293A1 | Solid forms of ceftolozane | |
US2015072968A1 | Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function |